Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brimonidine Tartrate 0.025% for Ocular Redness
NCT01675609Phase 2Completed
- Start
- Aug 2012
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of brimonidine in ocular redness. Started Aug 2012; status: completed.
02
Drugs
brimonidine
03
Conditions
ocular redness
Beyond the preview
Go deeper on NCT01675609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01675609.